Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation

5Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the course of research and development of a new pharmaceutical formulation of azelaic acid in the liposomal form, we developed a rapid and accurate method for the detection of impurities using high-performance liquid chromatography. A chromatographic column from Merck (Purospher Star RP C18, 250-4 mm (5 m) was used in the assay, and the mobile phase gradient consisted of three phases: A - methanol: water (5: 95) + 1.5% (v/v) acetic acid; B - water: methanol (5: 95) + 1.5% (v/v) acetic acid; and C - chloroform. Detection of the impurities and the active substance was performed by an evaporative light-scattering detector. The method was validated for selectivity, system precision, method precision, limit of detection, and response rates. The proposed method can be used to detect impurities in the liposomal formulation of azelaic acid. The method enables separation of azelaic acid from the identified and unidentified impurities and from the excipients used in the drug form. © 2013 Stanislaw Han et al.

Cite

CITATION STYLE

APA

Han, S., Karlowicz-Bodalska, K., Szura, D., Ozimek, L., & Musial, W. (2013). Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation. The Scientific World Journal, 2013. https://doi.org/10.1155/2013/564962

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free